A carregar...

RhoGDIα suppresses growth and survival of prostate cancer cells

BACKGROUND: Treatment for primary prostate cancer (CaP) is the withdrawal of androgens. However, CaP eventually progresses to grow in a castration-resistant state. The mechanisms involved in the development and progression of castration-resistant prostate cancer (CRPC) remain unknown. We have previo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhu, Yezi, Tummala, Ramakumar, Liu, Chengfei, Nadiminty, Nagalakshmi, Lou, Wei, Evans, Christopher P., Zhou, Qinghua, Gao, Allen C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961824/
https://ncbi.nlm.nih.gov/pubmed/21681778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21441
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!